Butyrate induces an EctoMg2+‐ATPase activity in Li‐7A human hepatoma cells

Publisher Website
Google Scholar
Abstract
The human hepatoma cell line (Li‐7A) possesses a high concentration of epider‐mal growth factor (EGF) receptors and exhibits ectoATPase activity in the presence of either MgATP or CaATP (Knowles: J. Cell. Physiol., 734:109–116, 1988). Growth for 96 hours in the presence of both EGF and cholera toxin or another cyclic AMP elevating agent induced an ectoATPase activity which was more active with CaATP and resistant to inhibition by the sulfhydryl reagent, p‐chloromercuriphenylsulfonate (pCMPS) (Knowles: Arch. Biochem. Biophys., 263: 264–271, 1988). In contrast, treatment of cells with butyrate, a short chain organic acid which can be derived from the analogue, dibutyryl cyclic AMP, resulted in a 4‐7‐fold increase of an ectoATPase which was more active with MgATP and highly sensitive to pCMPS inhibition. Maximal induction by butyrate required 48 hours and was dependent on butyrate concentration, but was independent of EGF and cyclic AMP elevating agents. Of six organic acids tested, butyrate was most effective in the induction of the ectoMg2+‐ATPase. The increase in the ectoMg2+‐ATPase activity could be prevented with actinomycin D and cycloheximide, indicating that both transcription and translation were necessary for induction. In addition to the induction of the ectoMg2+‐ATPase, bu‐tyrate induced alkaline phosphatase activity, but had no effect on a third ectoen‐zyme, 5′‐nucleotidase. These data further support our proposal that two distinct ectoATPases exist in the plasma membranes of Li‐7A hepatoma cells.

This publication has 33 references indexed in Scilit: